MetLife, Inc.

New York Stock Exchange
Back to all articles
Slightly Bullish +25

Is MetLife (MET) Offering Value After Recent 10.7% Share Price Gain? - simplywall.st

AI-generated analysis

📉 MetLife shares have recently gained 10.7% but only delivered a 3.8% total return over the last year.

🧮 An Excess Returns model calculates an intrinsic value of $183.78 per share for MetLife.

💸 The current market price is approximately $78.82, suggesting a 57.1% discount to the model's estimate.

📊 MetLife trades at a Price-to-Earnings (P/E) ratio of 14.81x based on current earnings.

🔍 This P/E multiple is higher than both the Insurance industry average (11.18x) and the peer group average (13.20x).

⚖️ Simply Wall St's proprietary Fair Ratio suggests a reasonable P/E of 14.91x, nearly identical to the current price.

🗣️ Investor narratives regarding fair value vary widely, ranging from $75 to $102 per share depending on risk factors and growth potential.

⚠️ The analysis highlights considerations such as interest rates, credit risk, technology execution, and international growth opportunities.

📝 This article utilizes historical data and analyst forecasts without constituting specific financial advice or a recommendation to buy.

🏢 MetLife operates globally providing insurance, annuities, employee benefits, and asset management services.

Bullish Signals
  • MetLife delivered strong 3.8% returns over the last year, demonstrating performance that competes favorably with the broader Insurance industry.
  • Based on an Excess Returns model using a book value of $41.69 and stable earnings per share estimate of $9.21, MetLife is estimated to have an intrinsic value of approximately $183.78 per share.
  • This analysis suggests MetLife is trading at a significant 57.1% discount compared to the recent share price of around $78.82, indicating substantial upside potential.
  • MetLife trades on a P/E ratio of 14.81x, which is above both the Insurance industry average of 11.18x and the peer group average of 13.20x, suggesting a quality valuation.
  • Simply Wall St's proprietary Fair Ratio estimate of 14.91x closely aligns with the current P/E of 14.81x, confirming the stock is priced at a fair level based on its specific fundamentals.
Risk Factors
  • The article explicitly notes that one market narrative anchors MetLife's fair value near the US$75 analyst target due to concerns regarding interest rates, credit risk, and technology execution.
  • MetLife trades at a P/E of 14.81x, which is above the Insurance industry average of 11.18x and the peer group average of 13.20x, suggesting a potentially richer valuation compared to sector benchmarks.
  • Analyst forecasts vary widely, with some valuations tied to US$75 specifically citing risks related to interest rate sensitivity and potential credit quality deterioration.
Full Analysis
MetLife (MET) shares have recently appreciated by 10.7%, yet Simply Wall St's Excess Returns model suggests the stock remains undervalued at approximately a 57% discount to its intrinsic value of $183.78 per share, based on a recent market price of around $78.82 and a stable book value estimate of $58.06. The analysis utilizes weighted future Return on Equity estimates from eight analysts projecting an average return of 15.86% against a cost of equity, resulting in calculated excess returns that drive the high intrinsic value figure. While traditional metrics like the Price-to-Earnings ratio show the stock trading at 14.81x earnings, which is slightly above the insurance industry and peer averages but nearly identical to Simply Wall St's proprietary Fair Ratio of 14.91x, the valuation gap in the Excess Returns model indicates a significant potential opportunity according to this specific framework. The article highlights that while narrative factors such as international growth or digital transformation could support higher valuations like the $102 analyst target, concerns regarding interest rates and credit risks might anchor expectations closer to the $75 target, illustrating how different investment stories translate into varying fair value estimates. The content focuses specifically on providing a fundamental data-driven analysis of MetLife's valuation rather than acting as a general market overview or financial advice. It distinguishes between broad industry P/E comparisons and the company-specific Fair Ratio tailored to MetLife's own fundamentals, while emphasizing that its methodology uses historical data and analyst forecasts without factoring in latest price-sensitive announcements. The article concludes with standard disclosures regarding the use of unbiased methodology, the non-advise nature of the commentary, and Simply Wall St's lack of position in the stock, directing readers toward a detailed Company Report for further insights into dividends, insider trades, and financial conditions.